Why Kate Tolo, the female Bryan Johnson, is taking a gentler approach to extreme biohackingNovember 22, 2026
General New combination therapy delivers durable responses for advanced ovarian cancerBy Healthcare Propulsion StaffNovember 20, 20260 Combining the experimental therapy IACS-6274 with targeted therapy bevacizumab and paclitaxel chemotherapy showed promising antitumor activity in a Phase 1…